Matthew Byerly, M.D.

Medical School

University of Arizona College of Med. (1990)

• Adult Psychiatry
• Mental Health

• Primary Interests
• Anxiety Disorder
• Depression
• Mood Disorder

• Educational interventions in psychiatric residency
• Efficacy and effectiveness of psychosocial and pharmacologic interventions of persons with schizophrenia
• Head-to-head comparisons of the efficacy and side effects of newer antipsychotics
• Phenomenology of antipsychotic non-adherence, and psychosocial interventions to improve antipsychotic non-adherence
• Prolactin and sexual effects of antipsychotic medications

Featured Publications

The NIMH-CATIE Project: Schizophrenia Trial Design and Protocol Development

Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick I, Canive J, McGee M, Simpson G, Stevens M, Lieberman JA. Schiz Bull. In press

Industry Sponsored Research Involving Newer Antipsychotic Agents for the Treatment of Schizophrenia: Does Source of Funding Influence Design and Outcome?

Montgomery J, Byerly MJ, Carmody T, Li G, Varghese F, Holland R. Submitted to Schiz Bull

Cost Evaluation of Risperidone Versus Olanzapine: A Database and Chart Review Study

Byerly M, Weber M, Brooks D, Casey SB, Elliot S, Cross J, McConnell D, Hawkins J. Psychiatr Serv 2003 54/5 742-744

Antipsychotic Medications and the Elderly: Effects on Cognition and Implications for Use

Byerly MJ, Weber M, Snow L, Worley M, Lescouflair E. Drugs and Aging 2001 18 45-61

• Faculty Teacher of the Year Award (3rd year resident class)
  2000-2001, UTSW (2001)
• Faculty Teacher of the Year Award (3rd year resident class)
  1999-2000, UTSW (2000)
• National Alliance for Research on Schizophrenia and Depression (NARSAD)
  1996-1998 (1998)
• Chief Resident’s Faculty Teacher of the Year Award, Department of Psychiatry,
  University of Florida College of Medicine, 1994-1995 (1995)
• Boris Zemsky Scholarship
  (Excellence of clinical performance in the field of Psychiatry) (1990)